• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
CAO Rongyue, CHANG Na, LI Manman, WANG Yunkang, WU Di, SHI Baoying, YUAN Yuting, LONG Jun. Preparation of mGM-CSF/βhCG fusion protein and the effect of its sensitized DC vaccine on RM-1 prostate tumor in mice[J]. Journal of China Pharmaceutical University, 2015, 46(1): 111-116. DOI: 10.11665/j.issn.1000-5048.20150117
Citation: CAO Rongyue, CHANG Na, LI Manman, WANG Yunkang, WU Di, SHI Baoying, YUAN Yuting, LONG Jun. Preparation of mGM-CSF/βhCG fusion protein and the effect of its sensitized DC vaccine on RM-1 prostate tumor in mice[J]. Journal of China Pharmaceutical University, 2015, 46(1): 111-116. DOI: 10.11665/j.issn.1000-5048.20150117
shu

Preparation of mGM-CSF/βhCG fusion protein and the effect of its sensitized DC vaccine on RM-1 prostate tumor in mice

More Information
    Graphical Abstract
    • Abstract
  • An expression vector pET-28a-mGM-CSF-X10-βhCGCTP37 plasmid containing the βhCG and mGM-CSF gene was designed and constructed. The fusion protein was induced by lactose and purified by ammonium sulfate precipitation and DEAE-cellulose anion exchange column. Then dendritic cells(DC)in C57BL/6J mice were extracted and sensitized by the fusion protein to obtain DC vaccine. The DC vaccine was inoculated to C57BL of / 6J mice with prostate cancer RM-1. The results indicated that the anti-tumor effects of DC group and DC combined with paclitaxel(DP)group were superior to that of paclitaxel(Pac)group(P< 0. 01), and the anti-tumor effect of DP group was better than that of DC group. Thus, the constructed DC vaccine can inhibit the growth of prostate cancer, and have synergistic anti-tumor when used with paclitaxel.
    • FullText(HTML)
    • References (13)
  • [1]
    Small EJ,Fratesi P,Reese DM, et al.Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells[J].J Clin Oncol,2000,18(23):3894-3903.
    [2]
    Abdulla A,Kappoor A.Emerging novel therapies in the treatment of castrate-resistant prostate cancer[J].Can Urol Assoc J,2011,5(2):120-133.
    [3]
    Sims RB.Development of sipuleucel-T:autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer[J].Vaccine,2012,30(29):4394-4397.
    [4]
    Iles RK,Delves PJ,Butler SA.Does hCG or hCGβ play a role in cancer cell biology[J].Mol Cell Endocrinol,2010,329(1/2):62-70.
    [5]
    Cole LA.hCG,five independent molecules[J].Clin Chim Acta,2012,413(1/2):48-65.
    [6]
    Cole LA.Hyperglycosylated hCG,a review[J].Placenta,2010,31(8):653-664.
    [7]
    Cole LA,Butler S.Hyperglycosylated hCG,hCGβ and hyperglycosylated hCGβ:interchangeable cancer promoters[J].Mol Cell Endocrinol,2012, 349(2):232-238.
    [8]
    Cheng YC,Valero V,Davis ML, et al.Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients[J].Br J Cancer,2010,103(9):1331-1334.
    [9]
    Somani J,Lonial S,Rosenthal H, et al.A randomized,placebo-controlled trial of subcutaneous administration of GM-CSF as a vaccine adjuvant:effect on cellular and humoral immune responses[J].Vaccine,2002,21(3/4):221-230.
    [10]
    Garcia F,Climent N,Assoumou L, et al.A therapeutic dendritic cell-based vaccine for HIV-1 infection[J].J Infect Dis,2011, 203(4):473-478.
    [11]
    Skalova K,Mollova K,Michalek J.Human myeloid dendritic cells for cancer therapy:does maturation matter[J]?Vaccine,2010,28(32):5153-5160.
    [12]
    Yin W,He Q,Hu Z, et al.A novel therapeutic vaccine of GM-CSF/TNFα surface-modified RM-1 cells against the orthotopic prostatic cancer[J].Vaccine,2010,28(31):4937-4944.
    [13]
    Inaba K,Inaba M,Romani N, et al.Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor[J].J Exp Med,1992, 176(6):1693-1702.
    • Related Articles

  • Related Articles

    [1]ZHAO Xiaomei, WANG Xin, JI Xia, Zhang Jing, ZHANG Hua, HU Guoqiang. Synthesis and antitumor activity of heteroatom-substituted azulenes derivatives of 1,2-benzothiazine[J]. Journal of China Pharmaceutical University, 2024, 55(5): 634-638. DOI: 10.11665/j.issn.1000-5048.2023120503
    [2]SUN Dongyu, GONG Jingxu, LI Xuwen, HAN Guanying, GUO Yuewei. Studies on methyl xestopongoate analogues:design, synthesis and antitumor activities[J]. Journal of China Pharmaceutical University, 2018, 49(4): 413-421. DOI: 10.11665/j.issn.1000-5048.20180405
    [3]LI Mingtao, XU Dan, XUE Wenjun, YOU Qidong, SUN Liping. Design, synthesis and antitumor activities of oxazolo［5, 4-d］pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(4): 425-431. DOI: 10.11665/j.issn.1000-5048.20170406
    [4]QIAO Yixue, MOU Yi, HUANG Zhangjian, AI Yong, KANG Fenghua, LAI Yisheng, ZHANG Yihua. Synthesis and antitumor activities of novel CDDO-Me analogues[J]. Journal of China Pharmaceutical University, 2015, 46(3): 289-293. DOI: 10.11665/j.issn.1000-5048.20150305
    [5]MAO Chunfang, XU Chenjun, WANG Xuemin, LI Xianghua, ZHANG Wei, WANG Xinyang, LING Yong. Design, synthesis and antitumor activity of farnesylthiosalicylamide derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(2): 162-168. DOI: 10.11665/j.issn.1000-5048.20150204
    [6]HU Kun, ZHOU Anfei, JIANG Hefei, XU Yuanyuan, HUANG Qianhui, YANG Jie, CHEN Xin, REN Jie. Synthesis and antitumor activities of podophyllotoxin derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 33-38. DOI: 10.11665/j.issn.1000-5048.20140105
    [7]CHENG Keguang, CHU Xiangwu, LIU Guanyan, SU Chunhua, DENG Shengping, PAN Hongmei. Synthesis and antitumor activities of 3-substituted estradiol-pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 26-32. DOI: 10.11665/j.issn.1000-5048.20140104
    [8]LIU Dexiu, PAN Huaying, SHI Hui, HUANG Xiaoying, LOU Hongxiang. Synthesis and antitumor activity of a novel bisbibenzyl derivative[J]. Journal of China Pharmaceutical University, 2013, 44(6): 515-519. DOI: 10.11665/j.issn.1000-5048.20130605
    [9]HU Kun, XU Hua-jin, XIN Wen-qun, CHEN Xin, REN Jie. Synthesis and antitumor activity of nitrogen mustard derivatives of formononetin[J]. Journal of China Pharmaceutical University, 2012, 43(2): 113-119.
    [10]ZHA Xiao-ming, ZHANG Fei-ran, SHAN Jia-qi, CHEN Yan-ke, ZHANG Yi-hua, LIU Jun, SUN Hong-bin. Synthesis and in vitro antitumor activities of novel soladulcidine derivatives[J]. Journal of China Pharmaceutical University, 2010, 41(6): 493-498.

Catalog

    Get Citation
    PDF
    XML
    Article views (1434) PDF downloads (2211) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：366189

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return